SEC Form 4 · accession 0001179110-15-005346
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David P Southwell
Director
Period of report
Mar 23, 2015
Accepted (ET)
Mar 23, 2015 · 5:58 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Mar 23, 2015 | S | 2,200 | $68.99 | D | 8,721 | D | |
| Common StockF3 | Mar 23, 2015 | S | 117 | $69.91 | D | 8,604 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 14, 2014 for the primary purposes of covering tax obligations associated with a restricted stock vesting event and diversification.
- F2This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.57 to $69.51 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $69.90 to $69.91 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.